Product is sold strictly for laboratory scientific research (RUO), not for human consumption
[2] AOD9401 was investigated separately in Zucker fatty rats and isolated adipose tissue
Not because it is the only device that can deliver GHK-Cu to the dermis, but because its design choices map cleanly onto the failure modes the literature has spent two decades pointing at
This makes it relevant to laboratory investigations involving receptor cross-talk, metabolic adaptation, glucose-associated signaling, appetite-associated pathway biology, energy expenditure models, substrate utilization, hepatic metabolic signaling, and adipose-associated response systems
An effective fat-loss tool typically influences at least one of these directly: BPC-157 has not been established as reliably effective in humans for any of those categories of fat loss
The absence of allosteric modulation from the RAMP ECD allows the CTR ECD to adopt a conformation that sits further from the receptor TMD than the position observed in the consensus cryo-EM map